Caris Life Sciences, a leading next-generation AI TechBio company and precision medicine pioneer, announced that Eric Matthews has joined the organization as Chief Business Officer, Biopharma Business Development.
Health Technology Insights: Neptune Medical’s Pathfinder Overtube Enables Procedures in Challenging Anatomy
In this role, Eric will provide strategic leadership to biopharma business development, and through his executive leadership, support Caris’ expanding portfolio of biopharma partnerships.
“We are excited to welcome Eric to Caris,” said Caris President David Spetzler, MS, PhD, MBA. “Eric’s proven track record in biopharma leadership and development strategy aligns perfectly with our corporate development efforts and strategic growth initiatives.”
Health Technology Insights: Avvio Medical Treats First Patients with Innovative Kidney Stone Therapy
“Caris has a tremendous reputation as an industry leader in precision medicine,” said Eric Matthews. “At this transformative time in healthcare, I look forward to partnering with biopharma leaders to revolutionize clinical development with AI-powered, actionable clinical insights and to maximize the potential of new therapies to achieve the shared goal of eradicating cancer.”
Most recently, Eric served as the Chief Commercial Officer at Arcus Biosciences. Prior to Arcus, he held the position of VP, Franchise Head, Immuno-Oncology Global Marketing at AstraZeneca. He’s also held various leadership roles at Genentech, Roche, InterMune and GSK. Throughout his career, Eric has been involved with the Family Ranch Foundation, a nonprofit organization that financially supports families facing life-threatening diseases. He is a graduate of Duke University with a Master of Business Administration – Health Sector Management and a Master of Public Policy – Healthcare Innovation. He also holds dual Bachelor of Science degrees from Duke University in Molecular Biology and Economics.
Health Technology Insights: Bain Capital and Botanic Properties Acquire Boston Property for Biomanufacturing
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
